Evolus Inc.
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Evolus Inc.
Evolus Inc is a performance beauty company with a customer-centric approach to delivering breakthrough products in the self-pay aesthetic market. The company's first commercial product is Jeuveau, a proprietary 900 kilodalton, purified botulinum toxin type A formulation indicated for the temporary improvement in the appearance of moderate to severe glabellar lines, also known as frown lines, in adults. Its primary market is the cash-pay aesthetic market, which includes medical products purchased by physicians and other customers that are then sold to consumers or used in procedures for aesthetic indications. It generates product revenue from the sale of Jeuveau in the United States and Europe, and service revenue from distribution partners in Canada.
Frequently asked questions
To buy Evolus Inc. stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Evolus Inc. by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Evolus Inc. is EOLS:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Evolus Inc. has its primary listing on NASDAQ. You can trade Evolus Inc. with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Evolus Inc. is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include Evolus Inc. as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like Evolus Inc..